NL8301063A - Gesubstitueerde 3,4-diamino-1,2,5-thiadiazolen met histamine h2-receptor antagonistische werkzaamheid; gesubstitueerde ethaandiimidamiden. - Google Patents

Gesubstitueerde 3,4-diamino-1,2,5-thiadiazolen met histamine h2-receptor antagonistische werkzaamheid; gesubstitueerde ethaandiimidamiden. Download PDF

Info

Publication number
NL8301063A
NL8301063A NL8301063A NL8301063A NL8301063A NL 8301063 A NL8301063 A NL 8301063A NL 8301063 A NL8301063 A NL 8301063A NL 8301063 A NL8301063 A NL 8301063A NL 8301063 A NL8301063 A NL 8301063A
Authority
NL
Netherlands
Prior art keywords
compound
formula
solvate
hydrate
thiadiazole
Prior art date
Application number
NL8301063A
Other languages
English (en)
Dutch (nl)
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of NL8301063A publication Critical patent/NL8301063A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/06—1,2,3-Thiadiazoles; Hydrogenated 1,2,3-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL8301063A 1982-03-29 1983-03-25 Gesubstitueerde 3,4-diamino-1,2,5-thiadiazolen met histamine h2-receptor antagonistische werkzaamheid; gesubstitueerde ethaandiimidamiden. NL8301063A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36320782A 1982-03-29 1982-03-29
US36320782 1982-03-29

Publications (1)

Publication Number Publication Date
NL8301063A true NL8301063A (nl) 1983-10-17

Family

ID=23429274

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8301063A NL8301063A (nl) 1982-03-29 1983-03-25 Gesubstitueerde 3,4-diamino-1,2,5-thiadiazolen met histamine h2-receptor antagonistische werkzaamheid; gesubstitueerde ethaandiimidamiden.

Country Status (30)

Country Link
JP (2) JPS58180477A (de)
KR (1) KR880002209B1 (de)
AT (1) AT386599B (de)
AU (2) AU557577B2 (de)
BE (1) BE896291A (de)
CH (2) CH660880A5 (de)
CS (2) CS250229B2 (de)
DD (2) DD219768A5 (de)
DE (1) DE3311281A1 (de)
DK (2) DK166677B1 (de)
ES (3) ES8404683A1 (de)
FR (2) FR2542741B1 (de)
GB (2) GB2117769B (de)
GR (1) GR78524B (de)
HU (2) HU196386B (de)
IE (1) IE55596B1 (de)
IL (1) IL68259A0 (de)
IT (1) IT1164633B (de)
LU (1) LU84716A1 (de)
MY (1) MY8700942A (de)
NL (1) NL8301063A (de)
NO (1) NO163055C (de)
NZ (1) NZ203726A (de)
OA (1) OA07356A (de)
PT (1) PT76459B (de)
SE (2) SE461040B (de)
SU (2) SU1419518A3 (de)
YU (1) YU44849B (de)
ZA (1) ZA832154B (de)
ZW (1) ZW7683A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2222083A (en) * 1982-12-14 1984-06-21 Smith Kline & French Laboratories Limited Pyridine derivatives
US4593039A (en) * 1984-04-02 1986-06-03 Merck & Co., Inc. 1-aryloxy-3-(substituted aminoalkylamino)-2-propanols
US4644006A (en) * 1984-06-22 1987-02-17 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
JPH0622828B2 (ja) * 1986-06-30 1994-03-30 フアナツク株式会社 直圧式型締機構
WO2022034121A1 (en) 2020-08-11 2022-02-17 Université De Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3018289A (en) * 1960-02-10 1962-01-23 Wyandotte Chemicals Corp Process for preparing oxamidines
GB1595291A (en) * 1976-09-21 1981-08-12 Smith Kline French Lab Pyrimidone and thiopyrimidone derivatives
DK160611C (da) * 1979-09-04 1991-09-16 Bristol Myers Squibb Co Analogifremgangsmaade til fremstilling af 3,4-disubstituerede 1,2,5-thiadiazol-1-oxider og -1,1-dioxider
DE3175201D1 (en) * 1980-04-30 1986-10-02 Merck & Co Inc Aminothiadiazoles as gastric secretion inhibitors
AU2222083A (en) * 1982-12-14 1984-06-21 Smith Kline & French Laboratories Limited Pyridine derivatives

Also Published As

Publication number Publication date
DD210909A5 (de) 1984-06-27
JPS58180477A (ja) 1983-10-21
ES8505978A1 (es) 1985-06-16
DK81192A (da) 1992-06-18
ES8505977A1 (es) 1985-06-16
NO163055C (no) 1990-03-28
NZ203726A (en) 1986-05-09
GR78524B (de) 1984-09-27
GB2117769B (en) 1985-08-29
IE830686L (en) 1983-09-29
YU74483A (en) 1986-02-28
ES520982A0 (es) 1984-05-16
LU84716A1 (fr) 1983-12-05
KR840004095A (ko) 1984-10-06
SE8301725D0 (sv) 1983-03-28
ZA832154B (en) 1983-12-28
GB8308518D0 (en) 1983-05-05
SE8301725L (sv) 1983-11-25
SE8704689L (sv) 1987-11-25
PT76459A (en) 1983-04-01
OA07356A (fr) 1984-08-31
HU196386B (en) 1988-11-28
SE464302B (sv) 1991-04-08
DK141383D0 (da) 1983-03-28
SE461040B (sv) 1989-12-18
AT386599B (de) 1988-09-12
BE896291A (fr) 1983-09-28
IT8348005A0 (it) 1983-03-28
CH655111A5 (de) 1986-03-27
SU1355123A3 (ru) 1987-11-23
JPH0568472B2 (de) 1993-09-29
CH660880A5 (de) 1987-05-29
HU188742B (en) 1986-05-28
SU1419518A3 (ru) 1988-08-23
IT1164633B (it) 1987-04-15
DE3311281A1 (de) 1983-11-24
ATA111083A (de) 1988-02-15
ZW7683A1 (en) 1984-01-04
KR880002209B1 (ko) 1988-10-18
DK81192D0 (da) 1992-06-18
AU6327286A (en) 1987-01-08
FR2597867A1 (fr) 1987-10-30
PT76459B (en) 1986-03-11
GB2117769A (en) 1983-10-19
FR2597867B1 (fr) 1989-12-08
ES527685A0 (es) 1985-06-16
AU557577B2 (en) 1986-12-24
AU1290783A (en) 1983-10-06
YU44849B (en) 1991-04-30
NO831100L (no) 1983-09-30
MY8700942A (en) 1987-12-31
GB2149406A (en) 1985-06-12
FR2542741A1 (fr) 1984-09-21
IE55596B1 (en) 1990-11-21
FR2542741B1 (fr) 1989-12-08
AU586037B2 (en) 1989-06-29
GB8432809D0 (en) 1985-02-06
ES527686A0 (es) 1985-06-16
ES8404683A1 (es) 1984-05-16
NO163055B (no) 1989-12-18
CS250229B2 (en) 1987-04-16
SE8704689D0 (sv) 1987-11-25
CS250240B2 (en) 1987-04-16
DK166677B1 (da) 1993-06-28
DD219768A5 (de) 1985-03-13
DK141383A (da) 1983-09-30
JPH06135925A (ja) 1994-05-17
IL68259A0 (en) 1983-06-15
GB2149406B (en) 1986-01-02

Similar Documents

Publication Publication Date Title
FI78695B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 1,2-diaminocyklobuten-3,4-dionderivat.
KR850001795B1 (ko) 2,4-이치환된 티아졸 유도체의 제조방법
FI81096B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 2-(n-substituerad guanidino)-4-heteroaryltiazolfoereningar.
SE416049B (sv) Forfarande for framstellning av 1,1-diaminoctylenderivat, som kan anvendas for hemning av vissa histaminverkningar
KR860001921B1 (ko) 1,4-디하이드로피리딘의 제조방법
KR860002036B1 (ko) 히스타민 h₂-길항제의 제조방법
NL8301063A (nl) Gesubstitueerde 3,4-diamino-1,2,5-thiadiazolen met histamine h2-receptor antagonistische werkzaamheid; gesubstitueerde ethaandiimidamiden.
CS259516B2 (en) Method of new heterocyclic compounds production
CS262417B2 (en) Process for preparing new 1h,3h-pyrrolo/1,2-c/-thiazoles
KR870000912B1 (ko) 디하이드로피리딘 유도체의 제조방법
US4528375A (en) Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
US4528377A (en) Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
US4528378A (en) Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
US4600779A (en) Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
GB2093450A (en) 2,1,3-benzothiadiazole derivatives
KR880002530B1 (ko) 치환된 에탄디이미드 아미드 및 그의 제조방법
US4588826A (en) Ethanediimidamide intermediates
EP0452076B1 (de) Thiazol- und Imidazolderivate und Zusammensetzungen gegen Magengeschwüre, die sie enthalten
DK169255B1 (da) Analogifremgangsmåde til fremstilling af thieno-isothiazol-1,1-dioxid-derivater og farmaceutisk acceptable salte heraf
US4578471A (en) Substituted amino alkyl pyridyl ethanediimidamides
KR900004321B1 (ko) 히스타민 h_2-섭수체 길항작용을 가진 치환 3,4-디아미노-1,2,5-티아디아졸류 및 그 제조방법
AU696007B2 (en) Use of unsubstituted and substituted N-(pyrrol-1-yl) pyridinamines as anticonvulsant agents
US4595758A (en) Ethanediimidamide intermediates
US4517366A (en) Intermediates for preparing 3,4-diamino-1,2,5-thiadiazoles
NO792276L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-fenylamino-imidazolin-(2)-derivater

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
DNT Communications of changes of names of applicants whose applications have been laid open to public inspection

Free format text: BRISTOL-MYERS SQUIBB COMPANY

BB A search report has been drawn up
BC A request for examination has been filed
BV The patent application has lapsed